Abbott India Q2 profit rises 83 percent to Rs 137.52 crore
New Delhi: Drug firm Abbott India reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.
It had posted a net profit of Rs75.02 crore for the corresponding period of last fiscal, Abbott India said in a filing to BSE.
The total income of the company also rose to Rs946.04 crore for the July-September quarter of 2017-18 as against Rs743.78 crore in the same quarter of 2016-17.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd